Evaluation of immunogenicity and efficacy of Fasciola hepatica tetraspanin TSP2 fused to E. coli heat-labile enterotoxin B subunit LTB adjuvant following intranasal vaccination of cattle

Beddoe, Travis; Zerna, Gemma; Spithill, Terry; Toet, Hayley

doi:10.26181/15088350.v2

Evaluation of immunogenicity and efficacy of Fasciola hepatica tetraspanin TSP2 fused to E. coli heat-labile enterotoxin B subunit LTB adjuvant following intranasal vaccination of cattle

journal contribution

posted on 2022-10-28, 05:55 authored by Travis BeddoeTravis Beddoe, Gemma ZernaGemma Zerna, Terry SpithillTerry Spithill, Hayley ToetHayley Toet

<p>Includes figure: Raw SDS-PAGE gels and western blots for figure 1 and 2 for paper titled <em>"Evaluation of immunogenicity and efficacy of Fasciola hepatica tetraspanin TSP2 fused to E. coli heat-labile enterotoxin B subunit LTB adjuvant following intranasal vaccination of cattle"</em></p>

History

Related Materials

1.
DOI - Is supplement to Evaluation of Immunogenicity and Efficacy of Fasciola hepatica Tetraspanin 2 (TSP2) Fused to E. coli Heat-Labile Enterotoxin B Subunit LTB Adjuvant Following Intranasal Vaccination of Cattle

School

School of Life Sciences

Publication Date

2021-08-02

Journal

Vaccines

Volume

9

Issue

11

Pagination

18 p.

Publisher

MDPI AG

ISSN

2076-393X

Rights Statement

Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). The accompanying figure is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.